NOVO-NORDISK $168.64

down -0.28


24/5/2013 04:24 PM  |  NYSE : NVO  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 17% - NVO has underperformed the S&P 500 by 8%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Novo Nordisk (NVO) Drug Delay Draws Option Bears

    By SchaeffersResearch

  2. Novo Plunges On FDA Action

    Investors Business Daily

  3. Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises

    Investors Business Daily

  4. Stocks Little Changed; Ruger Briefly Dips Below Entry

    Investors Business Daily

  5. Stocks Barely Dip; Starz Takes Off

    Investors Business Daily

  6. FDA Decision on Diabetes Drug Hurts Novo Nordisk, Helps Sanofi

    YCharts

  7. Stocks Hold Mild Losses; LinkedIn Hits New High

    Investors Business Daily

  8. Stocks Narrow To Thin Red Line; Generac Backslides

    Investors Business Daily

  9. Denmark ETF Decked by Novo Nordisk's Slide

    Benzinga

  10. Novo Nordisk Stock Falls, Sanofi Rises On Drug Delay

    Investors Business Daily

  11. Novo Nordisk Shares Tumble on FDA Letter

    FOXBusiness

  12. Futures Cut Back Early Advance; Novo Nordisk Tumbles On FDA News

    Investors Business Daily

  13. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga

  14. Novo Nordisk hit high on Q4

    Investors Business Daily

  15. Novo Nordisk Earnings Beat Views; Competition Looms

    Investors Business Daily

  16. Novo Nordisk Stock Hits High After Q4 Profit Beat

    Investors Business Daily

  17. Stocks Mixed At Midday; Novo Nordisk Hits New High

    Investors Business Daily

  18. Stocks Mixed At Midday; Novo Nordisk Hits New High

    Investors Business Daily

  19. Santarus Wins Drug Approval, Offers Bullish Guidance

    Investors Business Daily

  20. The 3 Most-Recommended Healthcare Stocks

    GuruFocus

  21. Foreign Drugmakers Holding Up, But Some Have Flaws

    Investors Business Daily

  22. Hemophilia Treatment Could Take A New Leap

    Investors Business Daily

  23. Novo Nordisk Offers Steady Gains To Go With Dividend

    Investors Business Daily

  24. Baxter buys dialysis firm

    Investors Business Daily

  25. Baxter International Buying Gambro For $4 Billion

    Investors Business Daily

  26. IBD 50: 5 Top Stocks Mutual Funds Are Loading Up On

    Investors Business Daily

  27. Novo Nordisk In Recovery Mode After Earlier Sell-Off

    Investors Business Daily

  28. Acquisitions Help Valeant Pharma Rise To The Top

    Investors Business Daily

  29. Stocks Push Ahead In Short Day; Taiwan Semiconductor Rallies

    Investors Business Daily

  30. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga

  31. Stocks Slide On Fiscal Cliff Worries; Retailers Hit

    Investors Business Daily

  32. Stocks Dive In Post-Election Riptide; Hospitals Rise

    Investors Business Daily

  33. Dow Leads Market Higher As Volume Swells

    Investors Business Daily

  34. Stocks Gain In Mixed Trade; Novo Nordisk Falters

    Investors Business Daily

  35. China Drug Market to Boom – Diabetes Alone a $3.2 Billion Business ...

    YCharts

  36. IBD 50 Outperforms Peer Indexes; Landscape Is Tough

    Investors Business Daily

  37. My 5 Favorite Health Care Growth Picks of the Next 5 Years

    GuruFocus

  38. Stocks Turn Down At Midday Despite Better Jobs Data

    Investors Business Daily

  39. Valeant Earnings, Guidance Beat Street's Estimates

    Investors Business Daily

  40. Novo Nordisk raises guidance

    Investors Business Daily

  41. Novo Nordisk Beats Estimates As FDA Decision Looms

    Investors Business Daily

  42. Novo Nordisk Earnings Beat Estimates; Guidance Up

    Investors Business Daily

  43. Novo Nordisk Posts 35% Rise In Q3 Profit, Lifts 2012 Forecast

    Benzinga

  44. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga

  45. Novo Nordisk Gets EU Nod for Long-Lasting Insulin Drug

    FOXBusiness

  46. Stocks Hitting 52-Week Highs

    Benzinga

  47. Novo Nordisk Shows Saucer Bases Reward Patient Investors

    Investors Business Daily

  48. Jazz Pharma Breaks Out From 20-Week Base

    Investors Business Daily

  49. Chinese Browser, Search Engine Qihoo Joins IBD 50

    Investors Business Daily

  50. Lululemon Among Four Stocks Stretching Onto IBD 50

    Investors Business Daily

  51. The $47 Billion Hole in Pharma's Near-Term Future

    YCharts

  52. Novo Nordisk CFO Explains Winning Diabetes Strategy

    Investors Business Daily

  53. Watson Pharma Sues FDA Over Rights To Generic Actos

    Investors Business Daily

  54. Google, Home Depot, Other Stocks Hit 52-Week Highs Tuesday

    FOXBusiness

  55. Express Scripts On Healthy IBD 50 List, Monster Off

    Investors Business Daily

  56. Novo Nordisk Ups Profit Dose

    Investors Business Daily

  57. Novo Nordisk raises outlook

    Investors Business Daily

  58. Novo Nordisk Beats Q2 Estimates But FDA Issues Linger

    Investors Business Daily

  59. Novo Nordisk, Recent IBD 50, Up On Q2 Earnings Beat

    Investors Business Daily

  60. Novo Nordisk Posts 29% Surge In Q2 Profit, Lifts Forecast

    Benzinga

  61. Four Investment Options Presented by Obesity and Related Health ...

    YCharts

  62. Pickings Are Slim For U.S.-Listed Foreign Stocks, ADRs

    Investors Business Daily

  63. Novo Nordisk to Initiate Phase 3 Development of Semaglutide

    Benzinga

  64. Questcor Up On Plans To Expand Acthar To New Markets

    Investors Business Daily

  65. Drug Makers Embroiled in Diabetes Race

    FOXBusiness

  66. Novo Says FDA Delay Due to Huge Size of Data Submitted, FDA Delay ...

    Benzinga

  67. The Definitive Scandinavian ETF Guide (EWD, GXF, EDEN)

    Benzinga

  68. Novo Nordisk

    Investors Business Daily

  69. Novo Nordisk Diabetes Drug Approved For Toddlers

    Investors Business Daily

  70. Novo Nordisk Announces FDA Approves Levemir® for Expanded Use in ...

    Benzinga

  71. Merck Q1 Diabetes Sales Miss

    at IBD

  72. Generic-drug makers

    at IBD

  73. Illumina Falls As Roche Doesn't Raise $6.5 Bil Offer

    at IBD

  74. Stocks Down Late After Fed Minutes; Apple Holds Gains

    at IBD

  75. Stocks Fall In Early Afternoon But Apple At New High

    at IBD

  76. Stocks Mixed At Midday In Weak Trade; Apple At New High

    at IBD

  77. Stocks Open Quietly Mixed; SXC Health Solutions Jumps

    at IBD

  78. Novo Nordisk

    at IBD

  79. Novo Nordisk Stock Up on Diabetes, Obesity Drug News

    at IBD

  80. Some Top ADRs Fare Well After Earnings Reports

    at IBD

  81. GlaxoSmithKline Swings To Profit But Shy Of Estimates

    at IBD

  82. Emerging Markets, Industrials, Tech Fuel Fund Gains

    at IBD

  83. Escaping Europe's Escapades In The Garden of EDEN

    at Benzinga

  84. Novo, Valeant, Other Foreign Drugmakers Behave Well

    at IBD

  85. Dividend Stock Leader Novo Nordisk Keeps Innovating

    at IBD
People viewing NVO also viewed: , , , , , ,
Marketplace
Trading Center